Profitelligence Profitelligence · Filing Ledger Open VEEV research →

Form 8-K · Current Report · Filed 2026-01-05

Veeva Announces $2 Billion Share Repurchase Program

On January 5, 2026, Veeva Systems Inc. announced its Board of Directors authorized a share repurchase program for up to $2 billion of Veeva's outstanding shares of Class A common stock. The program allows for repurchases through open market purchases, privately negotiated transactions, or other means in accordance with securities laws. The timing and total amount of repurchases will be determined by management based on various conditions. The program has a term of 2 years and may be canceled or suspended at any time without notice.

Filer
Veeva Systems Inc. VEEV · NYSE
Filed
Accession
0001393052-26-000003
CIK
0001393052
Signal
Medium impactHealthcare

Items reported

Item events

Reported Item

Share Repurchase Program Announced

Market reaction

Close before filing

$219.49

Next session

+8.4%

Since filing

-7.2%

Latest close

$203.78

What happened, not what will happen — closing prices around the filing date.

About Veeva Systems Inc.

Veeva Systems Inc. is a cloud-based software solutions provider focusing specifically on the life sciences industry. Its primary function is to develop and deliver specialized software tailored for companies in the pharmaceutical, biotechnology, and medical device sectors. Veeva's product suite includes applications for customer relationship management, content management, collaboration, and data analytics, facilitating enhanced operational efficiency and regulatory compliance. The company’s offerings are designed to optimize the critical aspects of a life sciences company's operations, such as clinical data management, regulatory submissions, and commercial activities. Veeva Systems plays a significant role in the growing digital transformation of the health-related industries, bridging the gap between advanced technological solutions and industry-specific requirements. Founded in 2007 and headquartered in Pleasanton, California, Veeva has established itself as a leader in its niche market, empowering its clients with innovative tools that streamline R&D processes and enhance their go-to-market capabilities.

Exchange NYSE Industry Health Information Services Company website ↗

Never miss another VEEV filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts